Skin Liquescence
NDC 83027-0054, Angelica Archangelica, Berberis Aquifolium, Berberis Vulgaris, Equisetum Arvense, Geranium Maculatum, Myrrha, Iris Versicolor, Thuja Occidentalis, Nux Vomica, Hypericum Perforatum, Human Growth Hormone (HGH), Mercurius Solubilis, Petroleum, Graphites, liquid, from Nutritional Specialties, Inc..
- Product NDC
- 83027-0054
- Status
- Listed
- Labeler
- Nutritional Specialties, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0054 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANGELICA ARCHANGELICA ROOT3 [hp_X]/mL
- BERBERIS AQUIFOLIUM ROOT BARK3 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK3 [hp_X]/mL
- EQUISETUM ARVENSE TOP3 [hp_X]/mL
- GERANIUM MACULATUM ROOT3 [hp_X]/mL
- MYRRH3 [hp_X]/mL
- IRIS VERSICOLOR ROOT4 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG6 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED8 [hp_X]/mL
- HYPERICUM PERFORATUM WHOLE10 [hp_X]/mL
- SOMATROPIN12 [hp_X]/mL
- MERCURIUS SOLUBILIS12 [hp_X]/mL
- KEROSENE12 [hp_X]/mL
- GRAPHITE16 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Human Growth Hormone [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Recombinant Human Growth Hormone [EPC]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83027-0054-1 | 83027005401 | 120 mL in 1 BOTTLE, GLASS (83027-0054-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83027-0054 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0054 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83027-0054. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.